Full Spectrum CBD Sleep Gummies with CBN + THC
Multi-cannabinoid sleep formulations combining CBD, CBN, and THC gummies are increasingly popular for sleep support. Clinical evidence on their efficacy and safety remains limited. Patients and clinicians should approach these products with careful…
Missouri AG Sues CBD American Shaman Over Kratom Products – KFVS12
Missouri Attorney General sues CBD American Shaman over kratom products, raising important regulatory and patient safety issues. This lawsuit highlights the challenges in overseeing CBD and kratom sales. Patients and clinicians should be aware of the…
Marijuana Rescheduling Foes File First Lawsuit, Target Trump CBD Promise
The marijuana rescheduling lawsuit challenges federal cannabis policy and CBD access. This legal battle affects medical cannabis prescribing authority and patient treatment continuity. Clinicians and patients should stay informed about these evolving…
Understanding New Hemp Regulatory Changes
Hemp regulatory changes directly impact product availability, quality standards, and legal clarity for patients using CBD and hemp-derived cannabinoids. Clinicians must understand evolving compliance requirements to guide patient access effectively.…
Photos: The Last Day Texas Stores Can Sell Smokeable Hemp Cannabis
Texas has enacted a smokeable hemp ban affecting legal sales of these products. This policy change impacts patients relying on rapid cannabinoid delivery methods. The texas smokeable hemp ban forces a shift to alternative hemp product forms.
Missouri Attorney General Takes Legal Action Against American Shaman for Kratom Products
Missouri attorney general sues American Shaman over kratom products, emphasizing regulatory confusion impacting patient safety. The lawsuit highlights the need for clinicians to verify product contents. This case underscores distinct legal and…
Will Medicinal Cannabis Help My Mental Health? Evidence and Risks
Medicinal cannabis demand for mental health soars despite limited clinical evidence. Patients report benefits for anxiety and PTSD, but risks remain significant. Clinicians emphasize careful risk assessment and monitoring.
Smart Approach to Marijuana Challenges Medicare Hemp Program Litigation
Medicare hemp program litigation underscores ongoing regulatory uncertainty impacting CBD coverage for patients. This lawsuit challenges Medicare's pathway for cannabis reimbursement. The litigation may delay broader access to cannabis therapeutics for…
Vlasic Labs CBD Products Qualify for CMS Pilot Program | Cannabis Business Times
Vlasic Labs CBD products have qualified for the CMS pilot program, signaling a key regulatory milestone. This CMS pilot program inclusion may influence insurance coverage and clinical practices. Clinicians should monitor this CMS pilot program as it…
Erectile CBD Gummies Review: A Practical Look at Claims, Evidence, and Everyday Use
This erectile CBD gummies review examines the claims and available evidence regarding their use for erectile dysfunction. While marketed for sexual health, clinical proof remains limited. Patients and clinicians should approach these products with…